| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.002 | 0.9 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.0036 | 1 |